Medicare Enrolled
Dr. Satinder Dhillon, MD
Hematology & Oncology · Brockton, MA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dhillon from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dhillon?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dhillon
Dr. Satinder Dhillon is a hematology & oncology specialist in Brockton, MA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Dhillon performed 45,846 Medicare services across 1,081 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dhillon received a total of $6,975 from 50 pharmaceutical and/or device companies across 378 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dhillon is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 3% volume in MA
$6,975 industry payments
Medicare Practice Summary
Medicare Utilization ↗45,846
Medicare services
Top 3% in MA for hematology & oncology
1,081
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,413 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
36,000 | $1 | $5 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
3,680 | $6 | $20 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
1,384 | $11 | $50 |
| Anti-nausea injection (ondansetron/Zofran) | 870 | $0 | $0 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
869 | $102 | $400 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
476 | $1 | $7 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
430 | $74 | $300 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
356 | $12 | $50 |
| Refilling and maintenance of implantable drug delivery pump This procedure involves refilling and maintaining an implanted pump or reservoir used for delivering medication. It ensures the device functions correctly to provide continuous drug delivery. |
286 | $97 | $400 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
218 | $0 | $1 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
204 | $147 | $461 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
203 | $24 | $100 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
193 | $1 | $2 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
165 | $109 | $525 |
| Extended office visit by clinical staff, first hour An extended office or outpatient visit provided by clinical staff lasting at least one hour. |
163 | $16 | $45 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
124 | $27 | $120 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
120 | $54 | $225 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
64 | $47 | $200 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
41 | $133 | $500 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
80.9% high complexity
11.6% medium
7.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,975
Total received (2018-2024)
Avg $1,395/year across 5 years
Top 29% in MA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
378
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,831 (97.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$144 (2.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$37
2023
$25
2020
$736
2019
$2,940
2018
$3,237
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$19
E.R. Squibb & Sons, L.L.C.
$18
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$639
E.R. Squibb & Sons, L.L.C.
$620
Janssen Biotech, Inc.
$515
AstraZeneca Pharmaceuticals LP
$508
Octapharma USA, Inc.
$342
Bayer HealthCare Pharmaceuticals Inc.
$303
Genentech USA, Inc.
$282
Eisai Inc.
$246
Astellas Pharma US Inc
$245
Merck Sharp & Dohme Corporation
$235
Exelixis Inc.
$225
Teva Pharmaceuticals USA, Inc.
$206
Novartis Pharmaceuticals Corporation
$188
Daiichi Sankyo Inc.
$182
Lexicon Pharmaceuticals, Inc.
$166
EISAI INC.
$158
Seattle Genetics, Inc.
$150
Takeda Pharmaceuticals U.S.A., Inc.
$137
Amgen Inc.
$129
Celgene Corporation
$122
Otsuka America Pharmaceutical, Inc.
$107
Clovis Oncology, Inc.
$104
SANOFI-AVENTIS U.S. LLC
$100
Lilly USA, LLC
$87
Heron Therapeutics, Inc.
$81
Alexion Pharmaceuticals, Inc.
$72
Pharmacyclics LLC, An AbbVie Company
$67
Gilead Sciences, Inc.
$65
Incyte Corporation
$58
Helsinn Therapeutics (U.S.), Inc.
$57
TESARO, Inc.
$56
Puma Biotechnology, Inc.
$52
Seagen Inc.
$46
Advanced Accelerator Applications
$40
GENZYME CORPORATION
$40
Mylan Institutional Inc.
$38
Boehringer Ingelheim Pharmaceuticals, Inc.
$36
Janssen Scientific Affairs, LLC
$35
Kite Pharma, Inc.
$26
Janssen Pharmaceuticals, Inc
$25
Agios Pharmaceuticals, Inc.
$25
Blue Earth Diagnostics Limited
$25
Myriad Genetic Laboratories, Inc.
$20
Shire North American Group Inc
$19
AMAG Pharmaceuticals, Inc.
$18
JAZZ PHARMACEUTICALS INC.
$18
Taiho Oncology, Inc.
$16
Mylan Pharmaceuticals Inc.
$15
Aurobindo Pharma USA, Inc.
$14
Foundation Medicine, Inc.
$13
Top 3 companies account for 25.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · Abraxane · Alecensa · Aliqopa · Avastin · Axumin · BAVENCIO · BENDEKA · Beleodaq · CALQUENCE · CUTAQUIG · CYRAMZA · Cabometyx · DARZALEX · ERBITUX · Enhertu · Erleada · FASLODEX · FERAHEME · FOUNDATIONONE · Fulphila · GILOTRIF · HTX-011 · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · Imbruvica · Inrebic · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · Kyprolis · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lutathera · MEKINIST · MYCHOICE CDX · MYLOTARG · NINLARO · Nerlynx · Nexavar · OCTAGAM · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPDIVO · Ogivri · PADCEV · PROMACTA · PYRUKYND · Pomalyst · Prolia · RETACRIT · Revlimid · Rubraca · SOLIRIS · SPRYCEL · STELARA · SUSTOL · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · ULTOMIRIS · VENCLEXTA · VERZENIO · VIZIMPRO · VPRIV · VYXEOS · Vitrakvi · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XGEVA · XOSPATA · XTANDI · Xermelo · Yescarta · ZEJULA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
271
Per 100K population
51.0
County median income
$109,698
Nearest hospital
GOOD SAMARITAN MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dhillon is a mixed practice specialist, with above-average Medicare volume (top 3% in MA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dhillon experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Dhillon performed 36,000 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dhillon receive payments from pharmaceutical companies?
Yes. Dr. Dhillon received a total of $6,975 from 50 companies across 378 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dhillon's costs compare to other hematology & oncology specialists in Brockton?
Dr. Dhillon's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dhillon) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Brockton
Browse hematology & oncology specialists in Brockton ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in MA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in MA
Which MA hematology & oncology specialists receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology